1Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China; 2Department of Head and Neck, Zhejiang Cancer Hospital, Hangzhou 310022, China; 3Department of Head and Neck Tumor, Fudan University Shanghai Cancer Center, Shanghai 200433, China; 4Department of General Surgery, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China; 5Department of Nuclear Medicine, The Sixth Affiliated Hospital of Shanghai Jiao Tong University, Shanghai 200025, China; 6Department of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China; 7Department of Head and Neck, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China; 8Sun Yat-sen University Cancer Center, Guangzhou 510060, China; 9Department of Thyroid and Breast, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China; 10Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; 11Department of Head and Neck, Bethune International Peace Hospital, Shijiazhuang 050082, China; 12Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China; 13Department of Head and Neck, Gansu Provincial Cancer Hospital, Lanzhou 730050, China; 14Department of Head and Neck, Beijing Children’s Hospital, Capital Medical University, Beijing 100045, China; 15Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjing 300060, China; 16Department of Thyroid, Head and Neck, Henan Cancer Hospital, Zhengzhou 450008, China; 17Department of Thyroid, Sino Japanese Union Hospital of Jilin University, Changchun 130033, China; 18Department of Head and Neck, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China; 19Department of General Surgery, The Second Affiliated Hospital of Guizhou Medical University, Kaili 556099, China; 20Department of Head and Neck, Beijing Cancer Hospital, Beijing 100142, China; 21Departments of Ultrasonography. Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China; 22Department of Head and Neck, Jilin Tumor Hospital, Changchun 130012, China; 23Department of Thyroid and Breast, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610047, China
第一作者机构:[1]Tianjin Med Univ Canc Inst & Hosp, Dept Head & Neck Tumor, Tianjin, Peoples R China;[2]Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China;[3]Tianjins Clin Res Ctr Canc, Tianjin 300060, Peoples R China;
通讯机构:[1]Tianjin Med Univ Canc Inst & Hosp, Dept Head & Neck Tumor, Tianjin, Peoples R China;[2]Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China;[3]Tianjins Clin Res Ctr Canc, Tianjin 300060, Peoples R China;
推荐引用方式(GB/T 7714):
Gao Ming,Ge Minghua,Ji Qinghai,et al.2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma[J].Cancer Biology & Medicine.2017,14(3):203-211.doi:10.20892/j.issn.2095-3941.2017.0051.
APA:
Gao, Ming,Ge, Minghua,Ji, Qinghai,Cheng, Ruochuan,Lu, Hankui...&Zheng, Xiangqian.(2017).2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma.Cancer Biology & Medicine,14,(3)
MLA:
Gao, Ming,et al."2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma".Cancer Biology & Medicine 14..3(2017):203-211